Research area
non-drug Melanoma trials
We list melanoma studies that test something other than a medication, biologic or supplement. Examples are a device, a procedure or a behavioral program. At Non-Drug Cancer Trials, our team helps you learn if a particular study might suit you.
Updated
- No cost to ask
- Taking part is voluntary
- Studies are independently reviewed
Non-drug melanoma studies in numbers
- non-drug melanoma studies recruiting in the U.S.
- 33
- states with a study site
- 44
- studies that accept healthy volunteers
- 2
Source: ClinicalTrials.gov. Data processed .
Find non-drug melanoma studies by state
These states have the most studies recruiting right now.
Texas
7 studies recruiting.
New Jersey
6 studies recruiting.
Florida
5 studies recruiting.
Ohio
5 studies recruiting.
California
4 studies recruiting.
New York
4 studies recruiting.
Non-drug melanoma studies recruiting now
As of November 18, 2026, 33 non-drug melanoma studies are recruiting participants in the United States, according to ClinicalTrials.gov. This site lists only studies that test something other than a medication, biologic or supplement, such as a device, a procedure or a behavioral program, as each study is coded in the registry. This is what they have in common.
What they test
- other approaches13
- procedures10
- behavioral approaches such as talk therapy or training9
- devices7
- radiation5
A study can test more than one.
Main purpose
- treating a condition12
- supportive care8
- prevention4
- other purposes3
Phase
- Early Phase 11
- Phase 25
- Phase 32
- No phase25
Studies of devices and behavioral approaches have no phase.
Who runs them
- university, hospital or other31
- industry2
Who they enroll
- adults (18 to 64)31
- older adults (65 and over)30
- mainly children and teens (under 18)2
2 also accept healthy volunteers.
These counts come from each study's public record and change as studies open and close. Browse every location to see what is recruiting near you.
Source: ClinicalTrials.gov. Data processed . Each bar shows a count as a share of all 33 studies.
Recently updated non-drug melanoma studies
The 6 studies whose public records changed most recently, with some of the places each is recruiting. Select a study to read its full record on ClinicalTrials.gov.
Comparing the Effectiveness of Less Invasive Procedures With the Current Standard of Care for the Treatment of Older Adults With Early-Stage Melanoma
- Phase 3
- Ages 75 and older
- All sexes
- Sponsor
- ECOG-ACRIN Cancer Research Group
- Recruiting in
- Albuquerque, NM · Anaconda, MT · Arroyo Grande, CA · and 140 more U.S. locations
- Registry record
- NCT07068074 · updated
High Dose-Rate Brachytherapy for the Treatment of Both Primary and Secondary Unresectable Liver Malignancies
- No phase
- Ages 19 and older
- All sexes
- Sponsor
- M.D. Anderson Cancer Center
- Recruiting in
- Houston, TX
- Registry record
- NCT05053555 · updated
Using an Artificial Intelligence (AI) Tool for Melanoma Diagnosis
- Phase 3
- Ages 18 and older
- All sexes
- Sponsor
- Memorial Sloan Kettering Cancer Center
- Recruiting in
- Basking Ridge, NJ · Commack, NY · Harrison, NY · and 4 more U.S. locations
- Registry record
- NCT07890415 · updated
Prebiotic Food-enriched Diet (PreFED) to Enhance the Microbiome and Response to First-line Immunotherapy in Unresectable Melanoma
- No phase
- Ages 18 and older
- All sexes
- Sponsor
- M.D. Anderson Cancer Center
- Recruiting in
- Houston, TX
- Registry record
- NCT06466434 · updated
A Study on How to Safely Guide Surgery for Melanoma and Similar Skin Tumors in Children Using Pathology and Genetic Information
- Phase 2
- Up to age 25
- All sexes
- Sponsor
- Children's Oncology Group
- Recruiting in
- Austin, TX · Houston, TX · Jacksonville, FL · and 10 more U.S. locations
- Registry record
- NCT07621614 · updated
A Pilot Study of ctDNA-Guided Immune Checkpoint Inhibitor Duration in Patients With Advanced Melanoma.
- No phase
- Ages 18 to 90
- All sexes
- Sponsor
- Rutgers, The State University of New Jersey
- Recruiting in
- New Brunswick, NJ
- Registry record
- NCT07830225 · updated
Source: ClinicalTrials.gov. Data processed . See every melanoma study recruiting in the United States on ClinicalTrials.gov.
About these listings
These listings come from ClinicalTrials.gov, the study registry run by the U.S. National Library of Medicine. The data were processed on November 18, 2026. We show part of each public record (its title, phase, sponsor, basic eligibility and some of the places it is recruiting) exactly as registered. Nothing in a record is reworded. This site lists only studies that test something other than a medication, biologic or supplement, such as a device, a procedure or a behavioral program, as each study is coded in the registry.
Non-Drug Cancer Trials does not run these studies and is not affiliated with their sponsors. A listing is not a recommendation, and only a study's own team can tell you whether you may be eligible. Follow the link on any study to read its full record and contact that team directly, or ask us and a coordinator will help you understand your options. How we source and check what we publish.
What non-drug melanoma studies look at
The melanoma studies on this site test something other than a medication, biologic or supplement. That could be a device, a procedure or a behavioral program. A single, specific question sits behind every one of them. Your tasks as a participant therefore depend on which study you look at.
We describe anything under test in a study as investigational. Researchers do not yet have full answers about its risks or how well it works. Finding those answers is why the study is run.
Who may be able to take part
Each non-drug melanoma trial sets its own entry rules. A team may look at how old you are. They may ask about your past health and any medicines you take now. They may also consider how melanoma affects you. Some trials also enroll people who do not have melanoma.
Working out whether you fit is not your job. At a screening visit, the study team checks that for you. Read how eligibility and screening work.
What taking part usually involves
A first conversation
A coordinator starts by describing the study in general terms. You get answers to your questions before anything else happens.
Informed consent
You receive the full details of the non-drug trial in writing from its team. That covers the risks already known. Agreeing or not is up to you.
Screening
The team asks about your health and runs tests. The answers tell them if this non-drug trial fits you. Some people who are screened do not go on to join.
Study visits
After you join, you go to visits planned ahead of time. At each one, the team follows how your health is doing. You may leave the trial whenever you choose.
Questions about non-drug melanoma studies
Do I need a diagnosis to join a study about melanoma?
This varies by study. A confirmed diagnosis is required for some. In others, you are assessed during screening. The study team will explain which applies to you.
Would I have to change the care I receive now?
Changes to the care you have now are not something to make alone. Whether that care can continue depends on the study: some permit it, some do not. You go through this with the study doctor. Before you decide, your own doctor can talk it through with you too.
Is there a cost to take part?
Participants generally pay nothing for study visits, study tests, or the device, procedure or program being studied. Read more about costs.
Ask about non-drug melanoma studies
We need only a little information to start. You will then hear from a coordinator about non-drug melanoma trials. Asking a question commits you to nothing.
Independent information
- Skin Cancer (Including Melanoma) — National Cancer Institute (NIH)
- What Are Clinical Trials? — National Cancer Institute (NIH)
- ClinicalTrials.gov study registry — ClinicalTrials.gov (National Library of Medicine)